| ASSURERX ASSUREX HEALTH INC.
1650903 06 Nov 2013 | on 22 Feb 2017 | Class 044 Class 044 Medical, Beauty & Agricultural Services Providing personalized healthcare and medical information, namely, providing information that will enable doctors and clinicians to select and recommend the appropriate drug and dosage levels for patients through the use of data obtained through personalized pharmacogenetic testing and bioinformatics analysis; and consultation services related thereto | | | ASSURERX DESIGN ASSUREX HEALTH INC.
1698221 15 Oct 2014 | on 05 Sep 2017 | Class 044 Class 044 Medical, Beauty & Agricultural Services Providing personalized healthcare and medical information, namely, providing medical information and reports that will enable doctors and clinicians to select and recommend the appropriate drug and dosage levels for patients through the use of data obtained through personalized pharmacogenetic testing and bioinformatics analysis; and consultation services related thereto; medical testing services for diagnostic and treatment purposes, namely, providing medical tests that measure, analyze and interpret genes of patients, environmental, and other factors to predict which drugs and/or treatment programs have the best opportunity for positive outcomes for patients, personalize medication selection and treatment options and choices for patients, identify potentially harmful drug interactions and calculate drug dosage adjustments for patients; providing medical information to patients and medical professionals in the form of reports for the foregoing medical testing services | | | ASSURERX DESIGN ASSUREX HEALTH INC.
1647716 15 Oct 2013 | on 23 Aug 2017 | Class 044 Class 044 Medical, Beauty & Agricultural Services Providing personalized healthcare and medical information, namely, providing medical information and reports that will enable doctors and clinicians to select and recommend the appropriate drug and dosage levels for patients through the use of data obtained through personalized pharmacogenetic testing and bioinformatics analysis; consultation services related to providing personalized healthcare and medical information that will enable doctors and clinicians to select and recommend the appropriate drug and dosage levels for patients through the use of data obtained through personalized pharmacogenetic testing and bioinformatics analysis; medical testing services for diagnostic and treatment purposes, namely, providing medical tests that measure, analyze and interpret genes of patients, environmental, and other factors to predict which drugs and/or treatment programs have the best opportunity for positive outcomes for patients, personalize medication selection and treatment options and choices for patients, identify potentially harmful drug interactions and calculate drug dosage adjustments for patients; providing medical information to patients and medical professionals in the form of reports for use in relation to medical testing services for diagnostic and treatment purposes, namely, providing medical tests that measure, analyze and interpret genes of patients, environmental, and other factors to predict which drugs and/or treatment programs have the best opportunity for positive outcomes for patients, personalize medication selection and treatment options and choices for patients, identify potentially harmful drug interactions and calculate drug dosage adjustments for patients. | |